https://www.taxtmi.com/news?id=64998 A unified summit merges biopharmaceutical product development and advanced 3D cell culture conferences to remove adoption bottlenecks, enable translation of organoids, organ on chip, microfluidics and New Approach Methodologies into development pipelines, foster industry-academic-policy collaboration for scale up and commercialization, and align Indian stakeholders with global regulatory trends emphasizing human relevant, non animal testing models for safety and efficacy assessment. en-us Wed, 17 Dec 2025 15:16:03 +0530 Wed, 17 Dec 2025 15:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=64998 A unified summit merges biopharmaceutical product development and advanced 3D cell culture conferences to remove adoption bottlenecks, enable translation of organoids, organ on chip, microfluidics and New Approach Methodologies into development pipelines, foster industry-academic-policy collaboration for scale up and commercialization, and align Indian stakeholders with global regulatory trends emphasizing human relevant, non animal testing models for safety and efficacy assessment. News - Wed, 17 Dec 2025 15:16:03 +0530 https://www.taxtmi.com/news?id=64998